Cetuximab or bevacizumab with combi chemo equivalent in KRAS wild-type MCRC
Saturday, June 28, 2014 - 21:01
in Health & Medicine
For patients with KRAS wild-type untreated colorectal cancer, adding cetuximab or bevacizumab to combination chemotherapy offers equivalent survival, researchers said.